🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to assess the safety of 52 weeks onc...
Status
Completed
Location
1237.22.81015 Boehringer Ingelheim Investigational Site
Start Date
2012-02
Trial ID
NCT01536262
Treatments Being Tested
This is a 4-week, multicenter, randomized, double-blind, parallel group and...
Status
Completed
Location
Ordination Dr. Robert Voves, 8330 Feldbach
Start Date
2016-03-08
Trial ID
NCT02683109
Treatments Being Tested
The primary objective of this study is to determine the optimum dose(s) of ...
Status
Completed
Location
1237.9.00152 Boehringer Ingelheim Investigational Site
Start Date
2008-07
Trial ID
NCT00720499
Treatments Being Tested
The objective of this study is to assess the efficacy and safety of 12 week...
Status
Completed
Location
1237.26.10620 Boehringer Ingelheim Investigational Site
Start Date
2013-11
Trial ID
NCT02006732
Treatments Being Tested
To demonstrate the efficacy of inhaled tiotropium + olodaterol via Respimat...
Status
Completed
Location
SEC Lung
Start Date
2020-01-08
Trial ID
NCT04223843
Treatments Being Tested
The overall objective is to assess the effect of once daily tiotropium + ol...
Status
Completed
Location
1237.19.10039 Boehringer Ingelheim Investigational Site
Start Date
2015-01-13
Trial ID
NCT02296138
Treatments Being Tested
The purpose of this study is to compare the systemic exposure to BI 1744 BS...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT02231177
Treatments Being Tested
The objective of the trial is to compare the lung function profile of once ...
Status
Completed
Location
1237.11.32002 Boehringer Ingelheim Investigational Site
Start Date
2013-10
Trial ID
NCT01969721
The overall objective of this study is to assess the efficacy and safety of...
Status
Completed
Location
1237.5.01038 Boehringer Ingelheim Investigational Site
Start Date
2011-09
Trial ID
NCT01431274
Treatments Being Tested
The primary objective of this trial is to investigate the effect of 6 weeks...
Status
Completed
Location
1237.14.01404 Boehringer Ingelheim Investigational Site
Start Date
2012-02
Trial ID
NCT01533935
Treatments Being Tested